Evommune (EVMN) Share-based Compensation (2024 - 2026)
Evommune (EVMN) reported Share-based Compensation of $3.5 million for Q1 2026, up 534.93% year-over-year from $544000.0 in Q1 2025, and down 17.68% quarter-over-quarter from $4.2 million in Q4 2025.
Evommune (EVMN) Share-based Compensation (2024 - 2026) Analysis & Trends
Evommune (EVMN) has 3 years of Share-based Compensation data on file, last reported at $3.5 million in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $3.5 million, up 534.93% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.8 million (changed N/A YoY), and the FY2025 annual result was $5.9 million, up 240.07% from the prior year.
- Share-based Compensation declined to $3.5 million in Q1 2026 per EVMN's latest filing, from $4.2 million in the prior quarter.
- Over five years, Share-based Compensation peaked at $4.2 million in Q4 2025 and troughed at $401000.0 in Q3 2024.
- A 3-year average of $1.6 million and a median of $552500.0 in 2025 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 749.39% in 2025 and fell as far as 39.9% in 2025.
- A 3-year view of Share-based Compensation shows it stood at $494000.0 in 2024, then surged by 749.39% to $4.2 million in 2025, then retreated by 17.68% to $3.5 million in 2026.
- Business Quant data shows EVMN's Share-based Compensation at $3.5 million in Q1 2026, $4.2 million in Q4 2025, and $561000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 166.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 26.47 Mn |
| 10 | Evommune | 695.29 Mn | 483.82 Mn | - | 3.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.45 Mn |
| Mar 31, 2026 | 3.45 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Dec 31, 2025 | 4.20 Mn |
| Sep 30, 2025 | 561,000.00 |
| Sep 30, 2025 | 561,000.00 |
| Mar 31, 2025 | 544,000.00 |
| Mar 31, 2025 | 544,000.00 |
| Dec 31, 2024 | 494,000.00 |
| Dec 31, 2024 | 494,000.00 |
| Sep 30, 2024 | 401,000.00 |
| Sep 30, 2024 | 401,000.00 |